The opportunity for investing in and profiting from participating in the musculoskeletal industry is impressive. Analysts are enthusiastic that the $16+ B worldwide market will continue growth with a CAGR conservatively estimated at 12% for the next 5-8 years. Within this industry, there are segments such as spine and orthobiologics that have even stronger growth projections.

Companies enjoy healthy margins and forecast a strong future fueled by the coming tidal wave of baby boomer consumers that will need the type of products and services offered by this industry. These same companies are anxious to seek out and purchase innovation that will allow them to grow and differentiate themselves in the market.

The key trends within the industry include less invasive surgery, non-fusion treatments for spine, earlier stage interventions, reducing hospital stays for procedures and containing costs for various treatments. Ideas, technologies and companies that can address these issues will profit from offering solutions for underserved or even unmet needs to large medical device companies eager to acquire and integrate innovative solutions into their product offering.